Palatin Technologies, Inc. (LON:0KF3)
London · Delayed Price · Currency is GBP · Price in USD 9.33
-0.25 (-2.61%)
Sep 25, 2026, 2:54 PM GMT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of 12.54 million as of September 25, 2026. Its market cap has increased by 85.04% in one year.
Market Cap
12.54M
Enterprise Value
5.08M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.33
ChartMarket Cap Chart
Since January 29, 2018, Palatin Technologies's market cap has decreased from 124.07M to 12.54M, a decrease of -89.89%. That is a compound annual growth rate of -23.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 12.54M | -64.34% |
| Dec 11, 2025 | 35.16M | 61.85% |
| Dec 31, 2024 | 21.72M | -43.72% |
| Dec 29, 2023 | 38.60M | 99.29% |
| Dec 28, 2022 | 19.37M | -79.00% |
| Dec 30, 2021 | 92.25M | -28.03% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 24.89M |
| IXICO | 16.20M |
| SkinBioTherapeutics | 16.20M |
| Oxford BioDynamics | 15.46M |
| Fusion Antibodies | 14.02M |
| Aptamer Group | 11.23M |
| Genflow Biosciences | 10.62M |
| Solvonis Therapeutics | 7.83M |